Category Archives: Hepatitis C

WHO Calls On Countries To Scale Up Hepatitis Services, Invest In Elimination

Source: Health Policy Watch 31st July 2019   80 percent of people with viral hepatitis lack access to services for prevention, testing & treatment. To address this gap, the World Health Organization calls on countries to invest in scaling up hepatitis … Continue reading

Posted in Hepatitis C, WHO | Leave a comment

People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India

New Delhi, 10 July 2018: Delhi Network of Positive People (DNP+) has filed today two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir. These … Continue reading

Posted in Drug prices, Hepatitis C, Indian Patent Law, Patent, Patent Opposition, Sec 3 (d) | Tagged , | Leave a comment

Patient Advocacy Successes in Fight for Medicines

by Fran Quigley, Health & Human Rights Journal | June 26, 2018 Access to essential medicines is a well-established component of the human right to health, but it is a right that remains elusive for millions of people across the globe. The … Continue reading

Posted in Access to Medecines, Biologics/Biosimilars, Cancer, Hepatitis C, Uncategorized | Leave a comment

MSF challenges Gilead’s unmerited patent in China for lifesaving hepatitis C medicine, Affordable generic versions from China could save millions of people’s lives

Source: Medecins Sans Frontieres |June 19, 2018 The international medical humanitarian organisation Médecins Sans Frontières (MSF) today filed a legal patent challenge at China’s State Intellectual Property Office (SIPO), requesting the invalidation of the patent granted to US pharmaceutical corporation … Continue reading

Posted in Hepatitis C, Patent, Patent Enforcement | Leave a comment

NGO alleges ‘stock-out’ of Hepatitis C drugs at city hospital

Source: PTI | Published: India Today New Delhi: An NGO today alleged that at a Delhi government hospital had run out of Hepatitis C medicines, causing inconvenience to patients. “After a prolonged struggle, DNP+ and patients with HCV (Hepatitis C … Continue reading

Posted in Hepatitis C, Uncategorized | Leave a comment

Focusing on Neglected Patients

Source: Lasker Foundation | April 25, 2018 Rachel Cohen is the regional executive director of the Drugs for Neglected Diseases initiative (DNDi), a nonprofit drug research and development organization focused on diseases such as leishmaniasis and sleeping sickness. Previously, she worked … Continue reading

Posted in Hepatitis C, HIV/Aids, Neglected Diseases, Uncategorized | Leave a comment

Patent on Hep C drug rejected in Ukraine: Price of sofosbuvir will significantly reduce

Source: The Ministry of Economic Development and Trade of Ukraine (MEDT) refused to grant the pharmaceutical company Gilead a patent for hepatitis C drug sofosbuvir.  On 2 March 2018, the MEDT issued the order (No. 305) which approved the … Continue reading

Posted in Hepatitis C, Sofosbuvir, Uncategorized | Leave a comment